David Bogoslaw

Laying the rails for broader stablecoin adoption 

As use cases for digital payment systems expand, more payment rails providers that can secure licenses across multiple critical markets will be needed. VCs are keen to back them.

FGV Capital’s sophomore fund bets on next-gen fintech

Fund II, which closed on $35m, attracted commitments from Reinsurance Group of America, MassMutual, Bank of America and the Stellar Development Foundation.

LPs drawn to Cross-Border's focus on women's and children's health

The Canadian VC's sophomore fund, which is targeting $125m, held a first close on $58m, with support from Ceniarth, Equality Fund, KfW, Skoll Foundation and Wire Group.

Hold or fold?

Airtable’s acquisition by Bending Spoons at a price below its cumulative capital raised is gaining attention as a cautionary tale, but some VCs see it as a bold move.

Jump Capital aims to speed AI adoption

The firm's eighth flagship has raised $350m to invest in companies developing 'picks and shovels' for AI.

Savano Capital Partners closes oversubscribed $252m Fund IV

With commitments from returning LPs, as well as new endowments, family offices and its first two public pension plans, the new fund has made 12 investments to date.

More than meets the eye

What fund managers are experiencing is more complex than the headline numbers suggest.

Ground State Ventures’ new partner sees quantum hitting commercial stride

Trained as a quantum scientific researcher, Kris Kaczmarek shifted his career focus to venture capital, excited by what a quantum-focused funds were building.

Chemistry Ventures launches $500m Fund II

Among the LPs in the firm’s debut fund were Alaska Retirement Management Board and Teachers Insurance and Annuity Association of America.

Nest launches first venture sleeve with Schroders Capital

Increasing the UK pension fund’s VC allocation to £200m, the dedicated VC sleeve signals Nest’s intent to strengthen its support for the asset class, part of a broader vision to expand its private markets exposure up to 30% by 2030.